- Home
- XMTR vs ANIP Comparison
XMTR vs ANIP Comparison
Compare XMTR & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XMTR
- ANIP
- Stock Information
- Founded
- XMTR 2013
- ANIP 2001
- Country
- XMTR United States
- ANIP United States
- Employees
- XMTR N/A
- ANIP N/A
- Industry
- XMTR Industrial Machinery/Components
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- XMTR Technology
- ANIP Health Care
- Exchange
- XMTR Nasdaq
- ANIP Nasdaq
- Market Cap
- XMTR 1.2B
- ANIP 1.2B
- IPO Year
- XMTR 2021
- ANIP N/A
- Fundamental
- Price
- XMTR $25.07
- ANIP $68.02
- Analyst Decision
- XMTR Buy
- ANIP Strong Buy
- Analyst Count
- XMTR 10
- ANIP 8
- Target Price
- XMTR $34.60
- ANIP $79.75
- AVG Volume (30 Days)
- XMTR 578.1K
- ANIP 361.8K
- Earning Date
- XMTR 05-08-2025
- ANIP 05-09-2025
- Dividend Yield
- XMTR N/A
- ANIP N/A
- EPS Growth
- XMTR N/A
- ANIP N/A
- EPS
- XMTR N/A
- ANIP N/A
- Revenue
- XMTR $545,529,000.00
- ANIP $614,376,000.00
- Revenue This Year
- XMTR $21.05
- ANIP $27.62
- Revenue Next Year
- XMTR $17.31
- ANIP $7.71
- P/E Ratio
- XMTR N/A
- ANIP N/A
- Revenue Growth
- XMTR 17.72
- ANIP 26.20
- 52 Week Low
- XMTR $11.08
- ANIP $52.50
- 52 Week High
- XMTR $45.33
- ANIP $70.00
- Technical
- Relative Strength Index (RSI)
- XMTR 40.57
- ANIP 66.14
- Support Level
- XMTR $24.02
- ANIP $65.28
- Resistance Level
- XMTR $27.57
- ANIP $69.33
- Average True Range (ATR)
- XMTR 1.23
- ANIP 2.32
- MACD
- XMTR 0.32
- ANIP 0.29
- Stochastic Oscillator
- XMTR 41.59
- ANIP 83.54
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.